Eli Lilly (LLY) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the ...

Eli Lilly stakes its trillion-dollar valuation on mid-stage data for a two-drug obesity combo, and the September 30 readout will reveal whether eloraTZP is a genuine franchise leap or an expensive ...

As Eli Lilly And Co LLY prepares to report third-quarter results in late October, Guggenheim analyst Seamus Fernandez ...

Berenberg upgrades Eli Lilly to Buy with a $1,400 target, citing GLP-1 demand, Foundayo catalysts, and M&A pipeline. Read ...

The drugmaker has a lot riding on continued clinical progress.

The big story today with Eli Lilly is its hugely successful GLP-1 drugs, but the long-term story is likely to be about its ...

This marks the second FDA approval for Inluriyo in less than a year, following its September 2025 approval as monotherapy for the treatment of adults with ER+, HER2-, ESR1-mutated MBC whose disease ...

QurCan will optimise genetic therapeutics using its technology, with Lilly overseeing further research and commercialisation.

Eli Lilly (LLY) stock gains 2% after Citigroup sets a Street-high $1,600 price target and Berenberg upgrades to Buy, citing ...

In 1876, Colonel Eli Lilly opened a small pharmaceutical company in Indianapolis with an idea that was, at the time, radical to some: make medicine that actually worked. He had witnessed soldiers die ...

The company logo etched in stone is seen at the headquarters campus of Eli Lilly and Company on March 17, 2024 in Indianapolis, Indiana. Lilly, a pharmaceutical company, employs more than 12.000 ...

Eli Lilly shed billions in market value over the past month while its underlying business kept breaking records, and now one major Wall Street firm sees a setup that almost never appears in a stock ...